The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients
- PMID: 17519907
- PMCID: PMC2359970
- DOI: 10.1038/sj.bjc.6603803
The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients
Abstract
The aim of the study is to determine the role of lymphadenectomy in advanced epithelial ovarian cancer. The data were obtained from the Surveillance, Epidemiology and End Results (SEER) program reported between 1988 and 2001. Kaplan-Meier estimates and Cox proportional hazards regression models were used for analysis. Of 13 918 women with stage III-IV epithelial ovarian cancer (median age: 64 years), 87.9% were Caucasian, 5.6% African Americans, and 4.4% Asians. A total of 4260 (30.6%) underwent lymph node dissections with a median number of six nodes reported. For all patients, a more extensive lymph node dissection (0, 1, 2-5, 6-10, 11-20, and >20 nodes) was associated with an improved 5-year disease-specific survival of 26.1, 35.2, 42.6, 48.4, 47.5, and 47.8%, respectively (P<0.001). Of the stage IIIC patients with nodal metastases, the extent of nodal resection (1, 2-5, 6-10, 11-20, and >20 nodes) was associated with improved survivals of 36.9, 45.0, 47.8, 48.7, and 51.1%, respectively (P=0.023). On multivariate analysis, the extent of lymph node dissection and number of positive nodes were significant independent prognosticators after adjusting for age, year at diagnosis, stage, and grade of disease. The extent of lymphadenectomy is associated with an improved disease-specific survival of women with advanced epithelial ovarian cancer.
Figures
Similar articles
-
Association of lymphadenectomy and survival in stage I ovarian cancer patients.Obstet Gynecol. 2007 Jan;109(1):12-9. doi: 10.1097/01.AOG.0000249610.95885.ef. Obstet Gynecol. 2007. PMID: 17197582
-
Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients.Cancer. 2006 Oct 15;107(8):1823-30. doi: 10.1002/cncr.22185. Cancer. 2006. PMID: 16977653
-
Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer.Am J Obstet Gynecol. 2006 Dec;195(6):1862-8. doi: 10.1016/j.ajog.2006.06.068. Am J Obstet Gynecol. 2006. PMID: 17132488
-
[The place of lumo-aortic and pelvic lymph node dissection in the treatment of ovarian cancer].J Chir (Paris). 2008 Dec;145 Spec no. 4:12S45-12S49. J Chir (Paris). 2008. PMID: 19194358 Review. French.
-
Lymphadenectomy in the surgical management of penile cancer.Eur Urol. 2009 May;55(5):1075-88. doi: 10.1016/j.eururo.2009.02.021. Epub 2009 Feb 23. Eur Urol. 2009. PMID: 19264390 Review.
Cited by
-
Survival benefits of retroperitoneal lymphadenectomy for optimally-resected advanced ovarian high-grade serous carcinoma: a multi-institutional retrospective study.J Gynecol Oncol. 2022 Jul;33(4):e40. doi: 10.3802/jgo.2022.33.e40. Epub 2022 Feb 21. J Gynecol Oncol. 2022. PMID: 35320889 Free PMC article.
-
Obesity does not affect the number of retrieved lymph nodes and the rate of intraoperative complications in gynecologic cancers.J Gynecol Oncol. 2010 Mar;21(1):24-8. doi: 10.3802/jgo.2010.21.1.24. Epub 2010 Mar 31. J Gynecol Oncol. 2010. PMID: 20379444 Free PMC article.
-
Survival effect of different lymph node staging methods on ovarian cancer: An analysis of 10 878 patients.Cancer Med. 2018 Sep;7(9):4315-4329. doi: 10.1002/cam4.1680. Epub 2018 Aug 18. Cancer Med. 2018. PMID: 30121963 Free PMC article.
-
Hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer.J Gynecol Oncol. 2018 Jul;29(4):e51. doi: 10.3802/jgo.2018.29.e51. Epub 2018 Mar 9. J Gynecol Oncol. 2018. PMID: 29770622 Free PMC article. No abstract available.
-
Earlier is not always better: Optimal time to initiate adjuvant chemotherapy after surgery for ovarian cancer.Arch Gynecol Obstet. 2025 Jul 11. doi: 10.1007/s00404-025-08095-3. Online ahead of print. Arch Gynecol Obstet. 2025. PMID: 40643609
References
-
- Arango HA, Hoffman MS, Roberts WS, DeCesare SL, Fiorica JV, Drake J (2000) Accuracy of lymph node palpation to determine need for lymphadenectomy in gynecologic malignancies. Obstet Gynecol 95: 553–556 - PubMed
-
- Baiocchi G, Grosso G, di Re E, Fontanelli R, Raspagliesi F, di Re F (1998) Systematic pelvic and paraaortic lymphadenectomy at second-look laparotomy for ovarian cancer. Gynecol Oncol 69: 151–156 - PubMed
-
- Benedetti Panici P, Maggioni A, Hacker N, Landoni F, Ackermann S, Campagnutta E, Tamussino K, Winter R, Pellegrino A, Greggi S, Angioli R, Manci N, Scambia G, Dell'Anna T, Fossati R, Floriani I, Rossi RS, Grassi R, Favalli G, Raspagliesi F, Giannarelli D, Martella L, Mangioni C (2005) Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 97: 560–566 - PubMed
-
- Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20: 1248–1259 - PubMed
-
- Burghardt E, Girardi F, Lahousen M, Tamussino K, Stettner H (1991) Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol Oncol 40: 103–106 - PubMed